Annual Accounts Payable
$13.91 M
-$123.30 K-0.88%
December 31, 2024
Summary
- As of March 13, 2025, CPIX annual accounts payable is $13.91 million, with the most recent change of -$123.30 thousand (-0.88%) on December 31, 2024.
- During the last 3 years, CPIX annual accounts payable has risen by +$4.27 million (+44.32%).
- CPIX annual accounts payable is now -0.88% below its all-time high of $14.04 million, reached on December 31, 2023.
Performance
CPIX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$13.91 M
+$1.86 M+15.40%
December 31, 2024
Summary
- As of March 13, 2025, CPIX quarterly accounts payable is $13.91 million, with the most recent change of +$1.86 million (+15.40%) on December 31, 2024.
- Over the past year, CPIX quarterly accounts payable has stayed the same.
- CPIX quarterly accounts payable is now -0.88% below its all-time high of $14.04 million, reached on December 31, 2023.
Performance
CPIX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CPIX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.9% | 0.0% |
| 3 y3 years | +44.3% | +21.6% |
| 5 y5 years | +39.2% | +39.2% |
CPIX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.9% | +44.3% | -0.9% | +44.3% |
| 5 y | 5-year | -0.9% | +44.3% | -0.9% | +68.7% |
| alltime | all time | -0.9% | +1305.3% | -0.9% | +819.4% |
Cumberland Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $13.91 M(-0.9%) | $13.91 M(+15.4%) |
| Sep 2024 | - | $12.06 M(-3.6%) |
| Jun 2024 | - | $12.51 M(-4.3%) |
| Mar 2024 | - | $13.08 M(-6.9%) |
| Dec 2023 | $14.04 M(+29.7%) | $14.04 M(+29.8%) |
| Sep 2023 | - | $10.82 M(-0.9%) |
| Jun 2023 | - | $10.91 M(-2.8%) |
| Mar 2023 | - | $11.22 M(+3.7%) |
| Dec 2022 | $10.82 M(+12.2%) | $10.82 M(-6.0%) |
| Sep 2022 | - | $11.51 M(+8.7%) |
| Jun 2022 | - | $10.59 M(-7.5%) |
| Mar 2022 | - | $11.45 M(+18.7%) |
| Dec 2021 | $9.64 M(-28.0%) | $9.64 M(+4.4%) |
| Sep 2021 | - | $9.23 M(+3.0%) |
| Jun 2021 | - | $8.96 M(-14.4%) |
| Mar 2021 | - | $10.47 M(-21.9%) |
| Dec 2020 | $13.40 M(+34.0%) | $13.40 M(+23.7%) |
| Sep 2020 | - | $10.83 M(+0.0%) |
| Jun 2020 | - | $10.83 M(+31.3%) |
| Mar 2020 | - | $8.25 M(-17.5%) |
| Dec 2019 | $9.99 M(-9.9%) | $9.99 M(+21.5%) |
| Sep 2019 | - | $8.23 M(-13.8%) |
| Jun 2019 | - | $9.54 M(+2.7%) |
| Mar 2019 | - | $9.29 M(-16.2%) |
| Dec 2018 | $11.09 M(+23.5%) | $11.09 M(+31.3%) |
| Sep 2018 | - | $8.45 M(-16.1%) |
| Jun 2018 | - | $10.07 M(+18.2%) |
| Mar 2018 | - | $8.52 M(-5.1%) |
| Dec 2017 | $8.98 M(+11.7%) | $8.98 M(+13.4%) |
| Sep 2017 | - | $7.92 M(+23.6%) |
| Jun 2017 | - | $6.41 M(-11.8%) |
| Mar 2017 | - | $7.27 M(-9.5%) |
| Dec 2016 | $8.04 M(+179.3%) | $8.04 M(+20.7%) |
| Sep 2016 | - | $6.66 M(+81.6%) |
| Jun 2016 | - | $3.67 M(-9.8%) |
| Mar 2016 | - | $4.07 M(+41.3%) |
| Dec 2015 | $2.88 M | $2.88 M(-30.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $4.13 M(+0.4%) |
| Jun 2015 | - | $4.11 M(+21.9%) |
| Mar 2015 | - | $3.37 M(+4.0%) |
| Dec 2014 | $3.24 M(+59.3%) | $3.24 M(+1.2%) |
| Sep 2014 | - | $3.21 M(-24.1%) |
| Jun 2014 | - | $4.22 M(-10.7%) |
| Mar 2014 | - | $4.72 M(+132.1%) |
| Dec 2013 | $2.04 M(-27.0%) | $2.04 M(-10.4%) |
| Sep 2013 | - | $2.27 M(-26.6%) |
| Jun 2013 | - | $3.09 M(-9.7%) |
| Mar 2013 | - | $3.43 M(+22.8%) |
| Dec 2012 | $2.79 M(+84.4%) | $2.79 M(-34.0%) |
| Sep 2012 | - | $4.23 M(+44.0%) |
| Jun 2012 | - | $2.94 M(+27.4%) |
| Mar 2012 | - | $2.30 M(+52.2%) |
| Dec 2011 | $1.51 M(-28.8%) | $1.51 M(-53.9%) |
| Sep 2011 | - | $3.28 M(+42.5%) |
| Jun 2011 | - | $2.30 M(+6.0%) |
| Mar 2011 | - | $2.17 M(+2.2%) |
| Dec 2010 | $2.12 M(-62.3%) | $2.12 M(-37.8%) |
| Sep 2010 | - | $3.42 M(-43.0%) |
| Jun 2010 | - | $5.99 M(-12.0%) |
| Mar 2010 | - | $6.81 M(+21.0%) |
| Dec 2009 | $5.63 M(+72.9%) | $5.63 M(-2.8%) |
| Sep 2009 | - | $5.80 M(+139.6%) |
| Jun 2009 | - | $2.42 M(+5.4%) |
| Mar 2009 | - | $2.30 M(-29.5%) |
| Dec 2008 | $3.26 M(+69.5%) | $3.26 M(+7.0%) |
| Sep 2008 | - | $3.04 M(+4.2%) |
| Jun 2008 | - | $2.92 M(-11.1%) |
| Mar 2008 | - | $3.29 M(+71.1%) |
| Dec 2007 | $1.92 M(-43.0%) | $1.92 M(-15.3%) |
| Sep 2007 | - | $2.27 M(-31.4%) |
| Jun 2007 | - | $3.31 M(+3.4%) |
| Mar 2007 | - | $3.20 M(-5.2%) |
| Dec 2006 | $3.37 M(+240.7%) | $3.37 M |
| Dec 2005 | $990.10 K | - |
FAQ
- What is Cumberland Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual accounts payable year-on-year change?
- What is Cumberland Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly accounts payable year-on-year change?
What is Cumberland Pharmaceuticals annual accounts payable?
The current annual accounts payable of CPIX is $13.91 M
What is the all time high annual accounts payable for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual accounts payable is $14.04 M
What is Cumberland Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, CPIX annual accounts payable has changed by -$123.30 K (-0.88%)
What is Cumberland Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of CPIX is $13.91 M
What is the all time high quarterly accounts payable for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly accounts payable is $14.04 M
What is Cumberland Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, CPIX quarterly accounts payable has changed by $0.00 (0.00%)